Table 3 Clinical outcomes of patients in the two groups
Variable | Spread group (n = 48) | None-spread group (n = 42) | P Value |
|---|---|---|---|
JOA score, mean ± SD | |||
Pre. | 11.35 ± 3.39 | 10.45 ± 3.20 | .200 |
Post. 1w | 14.02 ± 2.49 | 12.71 ± 2.87 | .023 |
Post. 3 m | 14.25 ± 2.52 | 13.74 ± 2.58 | .344 |
Post. 6 m | 14.88 ± 2.40 | 14.36 ± 2.47 | .317 |
Post. 12 m | 15.23 ± 1.89 | 15.10 ± 2.60 | .779 |
Post. 24 m | 14.46 ± 2.18 | 14.45 ± 2.74 | .991 |
VAS, mean ± SD | |||
Pre. | 7.21 ± 1.29 | 6.86 ± 1.34 | .208 |
Post. 1w | 5.96 ± 1.54 | 5.07 ± 1.30 | .004 |
Post. 3 m | 4.71 ± 1.37 | 4.74 ± 1.81 | .930 |
Post. 6 m | 4.56 ± 1.17 | 5.07 ± 1.96 | .132 |
Post. 12 m | 4.02 ± 0.81 | 3.88 ± 1.52 | .581 |
Post. 24 m | 3.46 ± 1.29 | 3.14 ± 1.26 | .245 |
Complications | |||
PE, No. (%) | 0 | 0 | |
SSI, No. (%) | 2 (4.17%) | 1 (2.38%) | |
NI, No. (%) | 1 (2.08%) | 0 | |
SD, No. (%) | 2 (4.17%) | 3 (7.14%) | |
Hematoma, No. (%) | 3 (6.25%) | 1 (2.38%) | |
CSFL, No. (%) | 0 | 1 (2.38%) | |
Mortality, No. (%) | 0 | 0 | |